[HTML][HTML] A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer

Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - journals.lww.com
Background: Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …

[HTML][HTML] A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer

Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - ncbi.nlm.nih.gov
Background: Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …

A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer.

Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - europepmc.org
Background Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …

A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer

Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - pubmed.ncbi.nlm.nih.gov
Background Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …

[HTML][HTML] A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer

Q Zhao, K Sun, X Lei, L Cai - Medicine, 2020 - journals.lww.com
Background: Whether the combination of gefitinib and chemotherapy is beneficial for
advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to …